Key Takeaways
- • InStudio Ventures launched a $50 million sports and performance fund anchored by minority stakes in NFL teams Buffalo Bills and Los Angeles Chargers, acquired through partnership with another institutional investor rather than direct NFL approval.
- • The fund structure targets a 3x multiple through a dual-asset strategy: prestige NFL and Formula 1 holdings provide credibility and historical S&P 500 outperformance, while the majority of capital deploys into early-stage sports technology startups leveraging artificial intelligence.
- • Springbok Analytics, an AI-powered health analytics startup that generates 3D muscle visualization from MRI data, represents the fund's core investment thesis; the company raised $5 million in Series A (valued at $25 million) with backing from the NBA's venture capital arm.
- • InStudio's approach circumvents the NFL's institutional investor ownership framework, which only approved eight private equity firms following rule changes in 2024, by investing indirectly through an established partner holding team equity.
Summary
InStudio Ventures, a Los Angeles-based venture capital firm, unveiled a $50 million sports investing fund on April 28, 2026, that combines marquee professional sports team stakes with early-stage technology investments to generate institutional-grade returns. The fund is anchored by minority positions in two NFL franchises—the Buffalo Bills and Los Angeles Chargers—as well as a stake in the Aston Martin Formula 1 team, all acquired through a partnership structure rather than direct league approval.
The fund structure reflects a calculated arbitrage between asset classes. Managing partner Danny Cortenraede explicitly positioned the NFL and F1 holdings as credibility enhancers and historical return generators, noting that these prestige assets have outperformed the S&P 500 over two decades. However, he temperate expectations for outsized returns on team equity itself, stating realistic targets of 3x fund-level multiples will derive primarily from investments in sports technology companies rather than team appreciation.
The thematic anchor for the fund's venture allocation is artificial intelligence applied to athletic performance and health analytics. Springbok Analytics, a portfolio company in which InStudio participated during its $5 million Series A funding round, exemplifies this strategy. The startup uses machine learning to convert MRI imaging into three-dimensional muscle volume visualizations, benchmarked against demographic and biometric cohorts, enabling precision athlete monitoring and injury prevention. Springbok's Series A valuation reached $25 million and attracted the NBA's venture capital arm, signaling validation from sports industry insiders.
InStudio's fund structure navigates around the NFL's formal institutional investor approval process, which in 2024 granted only eight private equity firms explicit ownership rights in franchises. By investing alongside an existing approved partner rather than seeking direct league accreditation, the firm gains exposure to marquee assets while maintaining flexibility to deploy capital toward higher-growth technology bets. This approach positions InStudio at the intersection of traditional sports equity and the emerging sports-tech venture ecosystem.
The fund structure reflects a calculated arbitrage between asset classes. Managing partner Danny Cortenraede explicitly positioned the NFL and F1 holdings as credibility enhancers and historical return generators, noting that these prestige assets have outperformed the S&P 500 over two decades. However, he temperate expectations for outsized returns on team equity itself, stating realistic targets of 3x fund-level multiples will derive primarily from investments in sports technology companies rather than team appreciation.
The thematic anchor for the fund's venture allocation is artificial intelligence applied to athletic performance and health analytics. Springbok Analytics, a portfolio company in which InStudio participated during its $5 million Series A funding round, exemplifies this strategy. The startup uses machine learning to convert MRI imaging into three-dimensional muscle volume visualizations, benchmarked against demographic and biometric cohorts, enabling precision athlete monitoring and injury prevention. Springbok's Series A valuation reached $25 million and attracted the NBA's venture capital arm, signaling validation from sports industry insiders.
InStudio's fund structure navigates around the NFL's formal institutional investor approval process, which in 2024 granted only eight private equity firms explicit ownership rights in franchises. By investing alongside an existing approved partner rather than seeking direct league accreditation, the firm gains exposure to marquee assets while maintaining flexibility to deploy capital toward higher-growth technology bets. This approach positions InStudio at the intersection of traditional sports equity and the emerging sports-tech venture ecosystem.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.